Economy/Home · Economy

Alteogen and Samsung Epis Holdings Surge Over 10%... Biosimilar Stocks Rally Together, KOSDAQ Rebounds Over 4%

The domestic stock market has rebounded from the previous day's plunge, with biosimilar-related stocks showing strength across the board. Alteogen and Samsung Epis Holdings recorded double-digit gains, while major names such as Celltrion and Samchundang Pharm joined the upward trend. As of 12:50 p.

Oseong Kwon
Staff Reporter
5 min read
Alteogen and Samsung Epis Holdings Surge Over 10%... Biosimilar Stocks Rally Together, KOSDAQ Rebounds Over 4%
CBC News

The domestic stock market has rebounded from the previous day's plunge, with biosimilar-related stocks showing strength across the board. Alteogen and Samsung Epis Holdings recorded double-digit gains, while major names such as Celltrion and Samchundang Pharm joined the upward trend.

As of 12:50 p.m. on the 16th, Alteogen was trading at 236,500 won, up 23,000 won (+10.77%) from the previous day. Samsung Epis Holdings was up 33,500 won at 337,500 won. Both stocks rose more than 10%, posting the most notable moves among biosimilar-related stocks.

Celltrion was also trading at 195,100 won, up 13,000 won (+7.14%) from the previous day. Celltrion Pharm rose 2,600 won (+7.11%) to 39,150 won, and Samchundang Pharm climbed 12,800 won (+6.64%) to 205,500 won. Bionex gained 6.45% to 6,110 won, and Hanall Biopharma rose 5.75% to 43,250 won. Other related stocks also continued rising, including ISU Abxis at 3,880 won (+5.43%), Hanmi Pharmaceutical at 406,000 won (+5.18%), and Green Cross at 130,400 won (+4.32%).

The simultaneous strength of biosimilar stocks on the day is notable as it coincides with a broad market rebound. At the same time, the KOSPI was up 198.21 points (3.56%) from the previous day at 5,752.43. The KOSDAQ was trading up 37.52 points (4.93%) at 798.34, aiming to recover the 800 level.

Previously, on the 15th, the domestic stock market experienced extreme volatility, with both the KOSPI and KOSDAQ plunging more than 7% each and circuit breakers triggered in both markets. As major indices rebounded in the session on the 16th, investor sentiment showed signs of partial recovery, centered on stocks that had suffered large declines the previous day. Biosimilar-related stocks are also interpreted to be expanding their gains amid this market mood.

However, it is still too early to judge whether today's rally is merely a technical rebound following short-term losses or will lead to a broader improvement in investment sentiment for the biotech sector. In particular, attention is focused on whether the KOSDAQ, now near the 800 level, can maintain its upward momentum in the afternoon session, and whether the strength of key bio-related stocks such as Alteogen and Samsung Epis Holdings will continue until the market close.

[※ This article is based on market prices as of 12:50 p.m. on the 16th; intraday stock prices and indices are subject to change. Investment decisions and any resulting responsibility rest with the investor.]

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.